Today, a delegation of six people, including Vice Mayor Lu Chang of Qian'an City Government, Party Secretary Liu Jijun of Qian'an Commerce and Investment Promotion Bureau, and Mayor Deng Xuejun of Dawuli Town in Qian'an City, visited our company's Shanghai headquarters for inspection. Chairman Liu Naiyu of our company and visiting leaders jointly discussed the current situation of the domestic biopharmaceutical industry and the international trends in the segmented field of pharmaceutical excipients.
In recent years, Qian'an City has continued to adjust its industrial structure, expand and strengthen the biopharmaceutical industry, and continuously expand the "four in one" industrial pattern of biopharmaceuticals, modern Chinese medicine, medical devices, and diagnostic reagents. Qian'an City grasps the development trend and relies on the Beijing Tianjin Hebei Medical and Health Characteristic Industry Base - High tech Zone Biomedical Industry Park to fully leverage the leading and demonstration role of leading enterprises such as Innot and Sunflower Pharmaceutical, to connect key links such as research and development, production, and circulation, and to build a "four in one" pattern of biopharmaceuticals, modern Chinese medicine, medical devices, and diagnostic reagents, and to strengthen the biopharmaceutical and emergency health industry cluster.
In October 2016, the country released the "Healthy China 2030" Plan Outline, vigorously developing new varieties of biopharmaceuticals, chemical drugs, high-quality traditional Chinese medicine, high-performance medical devices, new excipients and packaging materials, and pharmaceutical equipment. The plant-based hollow capsules developed by our company are a new type of pharmaceutical auxiliary material. Compared to traditional gelatin capsules, this product has advantages such as lower cost, better safety, and longer shelf life, making it an ideal substitute for gelatin capsules. In European and American countries, the use of plant capsules accounts for approximately 80% of the total capsule usage, while in China it is less than 5%.
Our company's Vegatable capsule project has broken through the technological blockade imposed by developed countries on China in this field, achieving import substitution, and is a perfect cross-border combination of new materials, biopharmaceuticals, and intelligent manufacturing. Plant capsule products can not only enhance the safety and brand value of drugs, health foods, and functional foods, but also help enterprises expand their domestic market. They can also promote the internationalization of domestic formulations and cater to global consumption trends.
The Vegatable capsule project has enormous market potential and development prospects, and at the same time, we also feel a significant responsibility. We will take this as an opportunity, under the leadership of Dayou Group, to promote the spiral integration of intelligent manufacturing and new materials through the formation of industrial clusters, and use high-tech to drive the transformation of traditional industries and achieve the transformation of old and new driving forces.
After the meeting, Lu Chang, Vice Mayor of Qian'an City Government, sincerely invited our company to conduct an on-site inspection in Qian'an City. We believe that through joint efforts and cooperation between both parties, we will promote the development of China's biopharmaceutical industry and pharmaceutical excipients, and make greater contributions to the cause of human health.
